𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective

✍ Scribed by Norah Terrault; Bruno Roche; Didier Samuel

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
156 KB
Volume
11
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Management of hepatitis C virus infectio
Management of hepatitis C virus infection in the setting of liver transplantation
✍ Hector Rodriguez-Luna; Hugo E. Vargas πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 1 views

Posttransplantation recurrence of hepatitis C virus infection is a universal phenomenon with a highly variable natural history. 2. Approximately 10% to 25% of hepatitis C virusinfected recipients of liver allografts will develop cirrhosis within 5 years' after transplantation. 3. The 1-year actuaria

Hepatitis B virus prevention strategies
Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen–positive liver donation: A survey of North American, European, and Asian-Pacific transplant programs
✍ Robert Perrillo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB

Prophylactic therapy is generally used to prevent reactivated hepatitis B after transplantation of an antibody to hepatitis B core antigen (anti-HBc)-positive liver. To gain insight into current practice, a questionnaire was e-mailed to 89 liver transplant physicians in the United States, Europe, an

The significance of metabolic syndrome i
The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation
✍ Ibrahim A. Hanouneh; Ariel E. Feldstein; Arthur J. McCullough; Charles Miller; F πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

Although hyperinsulinemia and its associated metabolic syndrome (MS) have been implicated in the progression of hepatic fibrosis in hepatitis C virus (HCV) patients, little is known about the consequences of MS after orthotopic liver transplantation (OLT). The aim of this study was to assess the ass

Outcomes in liver transplant recipients
Outcomes in liver transplant recipients with hepatitis B virus: Resistance and recurrence patterns from a large transplant center over the last decade
✍ Guy W. Neff; Christopher B. O'Brien; Jose Nery; Norah Shire; Marzia Montalbano; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

Hepatitis B virus (HBV) recurrence following liver transplantation (LTx) has been controllable primarily with the use of hepatitis B immune globulin (HBIg) and lamivudine (LAM). However, HBV resistance to LAM and/or HBIg has become an increasing problem prompting the use of newer antiviral agents. T